Zitvogel L, Daillère R, Roberti MP, Routy B, Kroemer G (2017) Anticancer effects of the microbiome and its products. Nat Rev Microbiol 15(8):465–478
Article CAS PubMed Google Scholar
Huffnagle GB, Dickson RP, Lukacs NW (2017) The respiratory tract microbiome and lung inflammation: a two-way street. Mucosal Immunol 10(2):299–306
Article CAS PubMed Google Scholar
Yagi K, Huffnagle GB, Lukacs NW, Asai N (2021) The lung microbiome during health and disease. Int J Mol Sci 22(19):1–13
Chotirmall SH, Gellatly SL, Budden KF, Mac Aogain M, Shukla SD, Wood DLA et al (2017) Microbiomes in respiratory health and disease: an Asia-Pacific perspective. Respirology 22(2):240–250
Budden KF, Shukla SD, Rehman SF, Bowerman KL, Keely S, Hugenholtz P et al (2019) Functional effects of the microbiota in chronic respiratory disease. Lancet Respir Med 7(10):907–920
Erb-Downward JR, Thompson DL, Han MK, Freeman CM, McCloskey L, Schmidt LA et al (2011) Analysis of the lung microbiome in the “healthy” smoker and in COPD. PLoS ONE 6(2):e16384
Article CAS PubMed PubMed Central Google Scholar
Hilty M, Burke C, Pedro H, Cardenas P, Bush A, Bossley C et al (2010) Disordered microbial communities in asthmatic airways. PLoS ONE 5(1):e8578
Article PubMed PubMed Central Google Scholar
Gomes S, Cavadas B, Ferreira JC, Marques PI, Monteiro C, Sucena M et al (2019) Profiling of lung microbiota discloses differences in adenocarcinoma and squamous cell carcinoma. Sci Rep 9(1):1–11
Valverde-Molina J, García-Marcos L (2023) Microbiome and asthma: microbial dysbiosis and the origins, phenotypes, persistence, and severity of asthma. Nutrients 15(3):486
Article CAS PubMed PubMed Central Google Scholar
Hu T, Dong Y, Yang C, Zhao M, He Q (2021) Pathogenesis of children’s allergic diseases: refocusing the role of the gut microbiota. Front Physiol 12:1–10
Natalini JG, Singh S, Segal LN (2023) The dynamic lung microbiome in health and disease. Nat Rev Microbiol 21:222–235
Article CAS PubMed Google Scholar
O’Dwyer DN, Ashley SL, Gurczynski SJ, Xia M, Wilke C, Falkowski NR et al (2019) Lung microbiota contribute to pulmonary inflammation and disease progression in pulmonary fibrosis. Am J Respir Crit Care Med 199(9):1127–1138
Article PubMed PubMed Central Google Scholar
Dickson RP, Erb-Downward JR, Huffnagle GB (2013) The role of the bacterial microbiome in lung disease. Expert Rev Respir Med 7(3):245–257
Article CAS PubMed PubMed Central Google Scholar
Esposito V, Lucariello A, Savarese L, Cinelli MP, Ferraraccio F, Bianco A et al (2012) Morphology changes in human lung epithelial cells after exposure to diesel exhaust micron sub particles (PM1.0) and pollen allergens. Environ Pollut 171:162–167
Article CAS PubMed Google Scholar
Brune K, Frank J, Schwingshackl A, Finigan J, Sidhaye VK (2015) Pulmonary epithelial barrier function: some new players and mechanisms. Am J Physiol-Lung Cell Mol Physiol 308(8):L731–L745
Article CAS PubMed PubMed Central Google Scholar
Boccia M, Aronne L, Celia B, Mazzeo G, Ceparano M, D’Agnano V et al (2020) COVID-19 and coagulative axis: review of emerging aspects in a novel disease. Monaldi Arch Chest Dis. https://doi.org/10.4081/monaldi.2020.1300
Roca J, Vargas C, Cano I, Selivanov V, Barreiro E, Maier D et al (2014) Chronic obstructive pulmonary disease heterogeneity: challenges for health risk assessment, stratification and management. J Transl Med 12(Suppl 2):S3
Article PubMed PubMed Central Google Scholar
Prasetyo A, Sadhana U, Budiman J (2021) Nasal mucociliary clearance in smokers: A systematic review. Int Arch Otorhinolaryngol 25(1):160–169
Sethi S, Maloney J, Grove L, Wrona C, Berenson CS (2006) Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 173(9):991–998
Article PubMed PubMed Central Google Scholar
Hirschmann JV (2000) Do bacteria cause exacerbations of COPD? Chest 118(1):193–203
Article CAS PubMed Google Scholar
Pragman AA, Kim HB, Reilly CS, Wendt C, Isaacson RE (2012) The lung microbiome in moderate and severe chronic obstructive pulmonary disease. PLoS ONE 7(10):e47305
Article CAS PubMed PubMed Central Google Scholar
Lin L, Li J, Song Q, Cheng W, Chen P (2022) The role of HMGB1/RAGE/TLR4 signaling pathways in cigarette smoke-induced inflammation in chronic obstructive pulmonary disease. Immunity, Inflamm Dis 10(11):e711
Gangemi S, Casciaro M, Trapani G, Quartuccio S, Navarra M, Pioggia G, et al (2015) Association between HMGB1 and COPD: a systematic review. Mediat Inflamm
Alpkvist H, Athlin S, Mölling P, Norrby-Teglund A, Strålin K (2018) High HMGB1 levels in sputum are related to pneumococcal bacteraemia but not to disease severity in community-acquired pneumonia. Sci Rep 8(1):1–9
Polosukhin VV, Cates JM, Lawson WE, Zaynagetdinov R, Milstone AP, Massion PP et al (2011) Bronchial secretory immunoglobulin a deficiency correlates with airway inflammation and progression of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 184(3):317–327
Article CAS PubMed PubMed Central Google Scholar
Baraldo S, Turato G, Badin C, Bazzan E, Beghé B, Zuin R et al (2004) Neutrophilic infiltration within the airway smooth muscle in patients with COPD. Thorax 59(4):308–312
Article CAS PubMed PubMed Central Google Scholar
Sze MA, Dimitriu PA, Hayashi S, Elliott WM, McDonough JE, Gosselink JV et al (2012) The lung tissue microbiome in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 185(10):1073–1080
Article PubMed PubMed Central Google Scholar
Dang AT, Marsland BJ (2019) Microbes, metabolites, and the gut-lung axis. Mucosal Immunol 12(4):843–850
Article CAS PubMed Google Scholar
Chen L-W, Chen P-H, Hsu C-M (2011) Commensal microflora contribute to host defense against Escherichia coli pneumonia through Toll-like receptors. Shock 36(1):67–75
Schuijt TJ, Lankelma JM, Scicluna BP, de Sousa e Melo F, Roelofs JJTH, de Boer JD et al (2016) The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia. Gut 65(4):575–583
Article CAS PubMed Google Scholar
Sprooten RTM, Lenaerts K, Braeken DCW, Grimbergen I, Rutten EP, Wouters EFM et al (2018) Increased small intestinal permeability during severe acute exacerbations of COPD. Respiration 95(5):334–342
Article CAS PubMed Google Scholar
Qu L, Cheng Q, Wang Y, Mu H, Zhang Y (2022) COPD and gut-lung axis: how microbiota and host inflammasome influence COPD and related therapeutics. Front Microbiol 13:868086
Article PubMed PubMed Central Google Scholar
Zou M, Zhang W, Xu Y, Zhu Y (2022) Relationship between COPD and GERD: a bibliometrics analysis. Int J Chron Obstruct Pulmon Dis 17:3045–3059
Article PubMed PubMed Central Google Scholar
Crowell MD, Zayat EN, Lacy BE, Schettler-Duncan A, Liu MC (2001) The effects of an inhaled beta(2)-adrenergic agonist on lower esophageal function: a dose-response study. Chest 120(4):1184–1189
Article CAS PubMed Google Scholar
Huang C, Liu Y, Shi G (2020) A systematic review with meta-analysis of gastroesophageal reflux disease and exacerbations of chronic obstructive pulmonary disease. BMC Pulm Med 20(1):2
Article PubMed PubMed Central Google Scholar
Yu F, Huang Q, Ye Y, Zhang L (2022) Effectiveness of proton-pump inhibitors in chronic obstructive pulmonary disease: a meta-analysis of randomized controlled trials. Front Med 9:841155
Agustí A, Celli BR, Criner GJ, Halpin D, Anzueto A, Barnes P et al (2023) Global initiative for chronic obstructive lung disease 2023 report: GOLD executive summary. Eur Respir J 61(4):2300239
Article PubMed PubMed Central Google Scholar
Contoli M, Pauletti A, Rossi MR, Spanevello A, Casolari P, Marcellini A et al (2017) Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD. Eur Respir J 50(4):1700451
Carrera-Salinas A, González-Díaz A, Ehrlich RL, Berbel D, Tubau F, Pomares X et al (2023) Genetic adaptation and acquisition of mac
留言 (0)